The role of single-domain antibodies (or nanobodies) in SARS-CoV-2 neutralization

The severe acute respiratory syndrome (SARS-CoV-2), a newly emerging of coronavirus, continues to infect humans in the absence of a viable treatment. Neutralizing antibodies that disrupt the interaction of RBD and ACE2 has been under the spotlight as a way of developing the COVID-19 treatment. Some...

Descripción completa

Detalles Bibliográficos
Autores principales: Zebardast, Arghavan, Hosseini, Parastoo, Hasanzadeh, Ali, latifi, Tayebeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514607/
https://www.ncbi.nlm.nih.gov/pubmed/34648139
http://dx.doi.org/10.1007/s11033-021-06819-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514607/
https://www.ncbi.nlm.nih.gov/pubmed/34648139
http://dx.doi.org/10.1007/s11033-021-06819-7

Ejemplares similares